| Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations KA Phillips, IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ... Human Reproduction 31 (5), 1126-1132, 2016 | 45 | 2016 |
| Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers IM Collins, RL Milne, PC Weideman, SA McLachlan, ML Friedlander, ... Med J Aust 199 (10), 680-3, 2013 | 35 | 2013 |
| Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into … IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ... J Clin Oncol 31 (31), 3920-5, 2013 | 32 | 2013 |
| The tubal hypothesis of ovarian cancer: caution needed IM Collins, SM Domchek, DG Huntsman, G Mitchell The lancet oncology 12 (12), 1089-1091, 2011 | 29 | 2011 |
| Assessing and managing breast cancer risk: Clinicians' current practice and future needs IM Collins, E Steel, GB Mann, JD Emery, A Bickerstaffe, A Trainer, ... The Breast 23 (5), 644-650, 2014 | 28 | 2014 |
| Women’s preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, N O’Reilly, ... SpringerPlus 3 (1), 264, 2014 | 23* | 2014 |
| iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management IM Collins, A Bickerstaffe, T Ranaweera, S Maddumarachchi, L Keogh, ... Breast cancer research and treatment 156 (1), 171-182, 2016 | 22 | 2016 |
| Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, KA Phillips, ... Patient education and counseling 96 (1), 106-112, 2014 | 21 | 2014 |
| Strategies for fertility preservation after chemotherapy awareness among Irish Cancer specialists IM Collins, MJ Kennedy Irish Medical Journal, 2011 | 15 | 2011 |
| Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease? KA Phillips, EJ Steel, I Collins, J Emery, M Pirotta, GB Mann, P Butow, ... Australian journal of primary health 22 (3), 255-261, 2016 | 12 | 2016 |
| Carboplatin Dosing in Ovarian Cancer: Problems and Pitfalls IM Collins, R Roberts-Thomson, D Faulkner, D Rischin, M Friedlander, ... International Journal of Gynecological Cancer 21 (7), 1213, 2011 | 12 | 2011 |
| Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor IM Collins, P Beddy, KJ O'BYRNE Acta oncologica 49 (6), 872-874, 2010 | 10 | 2010 |
| A Role for IGF-1R–Targeted Therapies in Small-Cell Lung Cancer? K Gately, I Collins, L Forde, B Al-Alao, V Young, M Gerg, F Feuerhake, ... Clinical Lung Cancer 12 (1), 38-42, 2011 | 9 | 2011 |
| Electronic clinical decision support systems attitudes and barriers to use in the oncology setting. IM Collins, O Breathnach, P Felle Irish Journal of Medical Science, 2012 | 8 | 2012 |
| Terminology and Details of the Diagnostic Process for Testis Cancer SS Connolly, PJA Daly, MSJ Floyd Jr, IM Collins, R Grainger, JA Thornhill The Journal of urology 185 (3), 876-880, 2011 | 8 | 2011 |
| Clinical Decision Aids in Colon Cancer; A Comparison of Two Predictive Nomograms IM Collins, F Kelleher, C Stuart, M Collins, J Kennedy Clinical Colorectal Cancer, 2011 | 7 | 2011 |
| Novel Approaches to Treatment of Leiomyosarcomas IM Collins, DM Thomas Current oncology reports, 1-7, 2011 | 7 | 2011 |
| Adjuvant trastuzumab in HER2-positive breast cancer. IM Collins, P Francis, L Mileshkin The New England journal of medicine 366 (7), 664; author reply 664, 2012 | 6* | 2012 |
| Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality FC Kelleher, M McKenna, C Collins, G Brady, I Collins, J Crown Acta oncologica 46 (5), 702-704, 2007 | 5 | 2007 |
| Rechallenge with imatinib in GIST: is more always RIGHT? D Urban, J Lewin, IM Collins, J Mooi, M Jefford The Lancet Oncology 15 (1), e2-e3, 2014 | 3 | 2014 |
